Scientists reveal steps leading to necrotizing fasciitis

January 16, 2014, Hebrew University of Jerusalem
Understanding how necrotizing fasciitis (flesh-eating disease) develops: This shows Prof. Emanuel Hanski of the Institute of Medical Research Israel Canada at the Hebrew University's Faculty of Medicine. Credit: Prof. Hanski

How does Streptococcus pyogenes, or Group A streptococcus (GAS)—a bacterial pathogen that can colonize humans without causing symptoms or can lead to mild infections—also cause life-threatening diseases such as necrotizing fasciitis (commonly known as flesh-eating disease) and streptococcal toxic shock syndrome?

This mystery has intrigued many researchers in the field. Now, researchers at the Hebrew University of Jerusalem's Faculty of Medicine have discovered how this bacterium turns deadly. This opens the door to possible future treatments to curb this and other potentially fatal bacteria.

Annually, GAS infections lead to at 500,000 deaths worldwide and cause severe consequences to those infected. The flesh-eating disease, in particular, is an extremely vicious infection which progresses rapidly throughout the of the body, often leaving doctors with little time to stop or delay its progress. The main treatments include administration of antibiotics and surgical removal of infected tissues. Yet despite prompt treatment, the bacteria disseminate and cause death in approximately 25% of patients.

In probing how GAS progresses, Prof. Emanuel Hanski of the Institute of Medical Research Israel Canada at the Hebrew University Faculty of Medicine, together with Ph.D. student Moshe Baruch and an international research team, discovered a novel mechanism that influences GAS virulence at the early steps of the infection. The results of their study are published in the scientific journal Cell.

They found that when GAS adheres and infects the host's cells, it delivers into these cells two streptolysin toxins. These toxins impair the body's mechanism for quality control of protein synthesis. This in turn triggers a defensive stress response which, among other things, also increases the production of the amino acid asparagine. GAS senses the increased asparagine level and alters its gene expression profile—and its rate of proliferation, which can be deadly in the host.

The research team further discovered that asparaginase, a protein that digests asparagine and is a widely-used chemotherapeutic agent against leukemia, arrests GAS growth in human blood and in a mouse model of human . Asparginase has never before been used to treat GAS infections.

The findings of this study constitute a major advance of the concept that understanding the metabolic changes occurring between the pathogen and its host during infection can lead to development of new and more effective treatments against infectious diseases.

Yissum Research Development Company, the technology transfer arm of the Hebrew University, registered a patent for the discovery and is seeking commercial partners to help develop effective therapies against invasive streptococcus infections.

Explore further: Typhoid Fever: A race against time

More information: An Extracellular Bacterial Pathogen Modulates Host Metabolism to Regulate Its Own Sensing and Proliferation, Moshe Baruch, Ilia Belotserkovsky, Baruch B. Hertzog, Miriam Ravins, Eran Dov, Kevin S. McIver, Yoann S. Le Breton, Yiting Zhou, Catherine Youting Chen, Emanuel Hanski, Cell - 16 January 2014 (Vol. 156, Issue 1, pp. 97-108)

Related Stories

Typhoid Fever: A race against time

January 16, 2014
The life-threatening disease typhoid fever results from the ongoing battle between the bacterial pathogen Salmonella and the immune cells of the body. Prof. Dirk Bumann's research group at the Biozentrum of the University ...

New vaccine protects against lethal pneumonia caused by staph bacteria

December 20, 2013
University of Iowa researchers have developed a new vaccine that protects against lethal pneumonia caused by Staphylococcus aureus (staph) bacteria, including drug-resistant strains like MRSA.

New understanding of chlamydial disease: Novel simultaneous RNA-Seq analysis tracks host/pathogen interactions

December 4, 2013
Investigators at the Institute for Genome Sciences at the University of Maryland School of Medicine have developed a new technique that can track the activity of a disease-causing microbe and the host cell response to that ...

Re-writing the research on the treatment of infection

October 10, 2013
(Medical Xpress)—A major breakthrough in the search for alternatives to antibiotics and the treatment of infection could provide microbiologists with a whole new insight into the way germs co-exist with or attack humans.

Study: Toys, books, cribs can harbor bacteria for long periods

December 24, 2013
(Medical Xpress)—Numerous scientific studies have concluded that two common bacteria that cause colds, ear infections, strep throat and more serious infections cannot live for long outside the human body. So conventional ...

Recommended for you

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.